12,297 research outputs found
Potential and limitations of plant virus epidemiology: lessons from the Potato virus Y pathosystem
Abstract Plant virus epidemiology provides powerful tools to investigate key factors that contribute to virus epidemics in agricultural crops. When successful, epidemiological approaches help to guide decisions regarding plant protection strategies. A recent example is epidemiological research on Potato virus Y (PVY) in Finnish seed potato production; this study led to the dentification of the main PVY vector species and helped to determine the timing of virus transmission. However, pathosystems rarely allow research to produce such clear-cut results. In fact, the notorious complexity of plant virus pathosystems, with multiple interactions between virus, vector, plant and environment, makes them often impenetrable even for advanced epidemiological models. This dynamic complexity questions the universal validity of employing epidemiological models that attempt to single out key factors in plant virus epidemics. Therefore, a complementary approach is needed that acknowledges the partly indeterministic nature of complex and evolving pathosystems. Such an approach is the use of diversity, imploying functionally complementary elements that can jointly buffer against environmental changes. I argue that for a wider range of plant production problems, the strategy of combining mechanistic and diversity-based approaches will provide potent and sustainable solutions. In addition, to translate insights from plant virus epidemiology into practice, improvements need to be made in knowledge transfer, both within the scientific community and between researchers and practitioners. Finally, moving towards more appropriate virus control strategies is only possible if economic interests of all stakeholders are in line with changing current practices
Spatial expansions and travelling waves of rabies in vampire bats
A major obstacle to anticipating the cross-species transmission of zoonotic diseases and developing novel strategies for their control is the scarcity of data informing how these pathogens circulate within natural reservoir populations. Vampire bats are the primary reservoir of rabies in Latin America, where the disease remains among the most important viral zoonoses affecting humans and livestock. Unpredictable spatiotemporal dynamics of rabies within bat populations have precluded anticipation of outbreaks and undermined widespread bat culling programs. By analysing 1146 vampire bat-transmitted rabies (VBR) outbreaks in livestock across 12 years in Peru, we demonstrate that viral expansions into historically uninfected zones have doubled the recent burden of VBR. Viral expansions are geographically widespread, but severely constrained by high elevation peaks in the Andes mountains. Within Andean valleys, invasions form wavefronts that are advancing towards large, unvaccinated livestock populations that are heavily bitten by bats, which together will fuel high transmission and mortality. Using spatial models, we forecast the pathways of ongoing VBR epizootics across heterogeneous landscapes. These results directly inform vaccination strategies to mitigate impending viral emergence, reveal VBR as an emerging rather than an enzootic disease and create opportunities to test novel interventions to manage viruses in bat reservoirs
Modelling the species jump: towards assessing the risk of human infection from novel avian influenzas
The scientific understanding of the driving factors behind zoonotic and pandemic influenzas is hampered by complex interactions between viruses, animal hosts and humans. This complexity makes identifying influenza viruses of high zoonotic or pandemic risk, before they emerge from animal populations, extremely difficult and uncertain. As a first step towards assessing zoonotic risk of Influenza, we demonstrate a risk assessment framework to assess the relative likelihood of influenza A viruses, circulating in animal populations, making the species jump into humans. The intention is that such a risk assessment framework could assist decisionmakers to compare multiple influenza viruses for zoonotic potential and hence to develop appropriate strain-specific control measures. It also provides a first step towards showing proof of principle for an eventual pandemic risk model. We show that the spatial and temporal epidemiology is as important in assessing the risk of an influenza A species jump as understanding the innate molecular capability of the virus.We also demonstrate data deficiencies that need to be addressed in order to consistently combine both epidemiological and molecular virology data into a risk assessment framework
Sequence-based prediction for vaccine strain selection and identification of antigenic variability in foot-and-mouth disease virus
Identifying when past exposure to an infectious disease will protect against newly emerging strains is central to understanding the spread and the severity of epidemics, but the prediction of viral cross-protection remains an important unsolved problem. For foot-and-mouth disease virus (FMDV) research in particular, improved methods for predicting this cross-protection are critical for predicting the severity of outbreaks within endemic settings where multiple serotypes and subtypes commonly co-circulate, as well as for deciding whether appropriate vaccine(s) exist and how much they could mitigate the effects of any outbreak. To identify antigenic relationships and their predictors, we used linear mixed effects models to account for variation in pairwise cross-neutralization titres using only viral sequences and structural data. We identified those substitutions in surface-exposed structural proteins that are correlates of loss of cross-reactivity. These allowed prediction of both the best vaccine match for any single virus and the breadth of coverage of new vaccine candidates from their capsid sequences as effectively as or better than serology. Sub-sequences chosen by the model-building process all contained sites that are known epitopes on other serotypes. Furthermore, for the SAT1 serotype, for which epitopes have never previously been identified, we provide strong evidence - by controlling for phylogenetic structure - for the presence of three epitopes across a panel of viruses and quantify the relative significance of some individual residues in determining cross-neutralization. Identifying and quantifying the importance of sites that predict viral strain cross-reactivity not just for single viruses but across entire serotypes can help in the design of vaccines with better targeting and broader coverage. These techniques can be generalized to any infectious agents where cross-reactivity assays have been carried out. As the parameterization uses pre-existing datasets, this approach quickly and cheaply increases both our understanding of antigenic relationships and our power to control disease
Wolbachia versus dengue: Evolutionary forecasts.
A novel form of biological control is being applied to the dengue virus. The agent is the maternally transmitted bacterium Wolbachia, naturally absent from the main dengue vector, the mosquito Aedes aegypti. Three Wolbachia-based control strategies have been proposed. One is suppression of mosquito populations by large-scale releases of males incompatible with native females; this intervention requires ongoing releases. The other interventions transform wild mosquito populations with Wolbachia that spread via the frequency-dependent fitness advantage of Wolbachia-infected females; those interventions potentially require just a single, local release for area-wide disease control. One of these latter strategies uses Wolbachia that shortens mosquito life, indirectly preventing viral maturation/transmission. The other strategy uses Wolbachia that block viral transmission. All interventions can be undermined by viral, bacterial or mosquito evolution; viral virulence in humans may also evolve. We examine existing theory, experiments and comparative evidence to motivate predictions about evolutionary outcomes. (i) The life-shortening strategy seems the most likely to be thwarted by evolution. (ii) Mosquito suppression has a reasonable chance of working locally, at least in the short term, but long-term success over large areas is challenging. (iii) Dengue blocking faces strong selection for viral resistance but may well persist indefinitely at some level. Virulence evolution is not mathematically predictable, but comparative data provide no precedent for Wolbachia increasing dengue virulence. On balance, our analysis suggests that the considerable possible benefits of these technologies outweigh the known negatives, but the actual risk is largely unknown
A Comparative Analysis of Influenza Vaccination Programs
The threat of avian influenza and the 2004-2005 influenza vaccine supply
shortage in the United States has sparked a debate about optimal vaccination
strategies to reduce the burden of morbidity and mortality caused by the
influenza virus. We present a comparative analysis of two classes of suggested
vaccination strategies: mortality-based strategies that target high risk
populations and morbidity-based that target high prevalence populations.
Applying the methods of contact network epidemiology to a model of disease
transmission in a large urban population, we evaluate the efficacy of these
strategies across a wide range of viral transmission rates and for two
different age-specific mortality distributions. We find that the optimal
strategy depends critically on the viral transmission level (reproductive rate)
of the virus: morbidity-based strategies outperform mortality-based strategies
for moderately transmissible strains, while the reverse is true for highly
transmissible strains. These results hold for a range of mortality rates
reported for prior influenza epidemics and pandemics. Furthermore, we show that
vaccination delays and multiple introductions of disease into the community
have a more detrimental impact on morbidity-based strategies than
mortality-based strategies. If public health officials have reasonable
estimates of the viral transmission rate and the frequency of new introductions
into the community prior to an outbreak, then these methods can guide the
design of optimal vaccination priorities. When such information is unreliable
or not available, as is often the case, this study recommends mortality-based
vaccination priorities
- …